![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: McCubrey James A Steelman Linda S Abrams Steven L Chappell William H Russo Suzanne Ove Roger Milella Michele Tafuri Agostino Lunghi Paolo Bonati Antonio Stivala Franca Nicoletti Ferdinando Libra Massimo Martelli Alberto M Montalto Giuseppe Cervello Melchiorre
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 203-223
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MEK inhibitors: a patent review 2008 –– 2010
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Recent Advances of MEK Inhibitors and Their Clinical Progress
Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-01 ,pp. :